| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 14 | +50.00% | +3.77% | +0.22% | +3.55% | +0.07% | — |
| 14d | 14 | +42.86% | +8.59% | -0.53% | +9.13% | +6.93% | — |
| 30d | 14 | +42.86% | -1.72% | -2.52% | +0.81% | +3.76% | — |
| 60d | 14 | +50.00% | -12.86% | -3.50% | -9.36% | -2.49% | — |
| 90d | 14 | +71.43% | -5.27% | +2.29% | -7.56% | -22.69% | — |
| 180d | 14(3 pending) | +90.91% | -45.31% | +2.26% | -47.57% | -56.76% | — |
| 1y | 14(4 pending) | +100.00% | -57.02% | +4.28% | -61.30% | -64.29% | — |
| 2y | 14(4 pending) | +90.00% | -56.59% | +21.14% | -77.74% | -83.62% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TSHA TAYSHA GENE THERAPIES, INC. | SALE CHIEF FINANCIAL OFFICER | 1,655 | $4.52 | $7.5K | 1,442,131 | Feb 4, 2026 | Feb 6, 2026 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE CHIEF FINANCIAL OFFICER | 23,849 | $4.61 | $109.9K | 1,443,786 | Jan 26, 2026 | Jan 27, 2026 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE CHIEF FINANCIAL OFFICER | 78,968 | $4.75 | $375.1K | 1,467,635 | Jan 23, 2026 | Jan 27, 2026 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 231,000 | — | — | 231,000 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 359,000 | — | — | 1,546,603 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE CHIEF FINANCIAL OFFICER | 54,491 | $2.85 | $155.3K | 1,187,603 | Aug 21, 2025 | Aug 22, 2025 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE CHIEF FINANCIAL OFFICER | 29,843 | $1.69 | $50.4K | 1,242,094 | Mar 11, 2025 | Mar 12, 2025 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 431,000 | — | — | 1,271,937 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 431,000 | — | — | 431,000 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE CHIEF FINANCIAL OFFICER | 1,288 | $1.51 | $1.9K | 840,937 | Feb 2, 2024 | Feb 6, 2024 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 590,413 | — | — | 842,225 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 590,413 | — | — | 590,413 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 187,582 | — | — | 187,582 | Dec 14, 2023 | Dec 18, 2023 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE10b5-1 10b5-1 plan | 33,000 | $2.33 | $76.9K | 258,042 | Aug 24, 2023 | Aug 25, 2023 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 12,462 | — | — | 12,462 | May 31, 2023 | Apr 10, 2025 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 6,230 | — | — | 291,042 | May 31, 2023 | Jun 2, 2023 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 37,384 | — | — | 37,384 | Feb 2, 2023 | Feb 6, 2023 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 18,691 | — | — | 284,812 | Feb 2, 2023 | Feb 6, 2023 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 149,900 | — | — | 149,900 | Feb 2, 2023 | Feb 6, 2023 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 3,325 | $3.47 | $11.5K | 266,121 | Aug 23, 2022 | Aug 24, 2022 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 9,717 | $3.50 | $34.0K | 269,446 | Aug 22, 2022 | Aug 22, 2022 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 11,482 | $3.75 | $43.1K | 279,163 | Aug 19, 2022 | Aug 22, 2022 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 7,476 | $3.87 | $28.9K | 290,645 | Aug 18, 2022 | Aug 22, 2022 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Apr 6, 2022 | Apr 8, 2022 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Feb 23, 2022 | Feb 25, 2022 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 2,094 | $17.14 | $35.9K | 298,121 | Aug 20, 2021 | Aug 20, 2021 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 9,746 | $16.70 | $162.8K | 300,215 | Aug 20, 2021 | Aug 20, 2021 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 613 | $17.11 | $10.5K | 309,961 | Aug 19, 2021 | Aug 20, 2021 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 9,354 | $16.43 | $153.7K | 310,574 | Aug 19, 2021 | Aug 20, 2021 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | SALE Chief Financial Officer | 11,193 | $17.35 | $194.2K | 319,928 | Aug 18, 2021 | Aug 20, 2021 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 70,000 | Jan 19, 2021 | Jan 20, 2021 ↗ | View → |
| TSHA TAYSHA GENE THERAPIES, INC. | PURCHASEGRANT Stock grant | 331,121 | — | — | 331,121 | Sep 23, 2020 | Sep 25, 2020 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 3,000 | — | — | 3,000 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,000 | — | — | 25,000 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |